Multiple Sclerosis Medications

Multiple sclerosis (MS) medications are drugs that can help reduce symptoms and slow the progression of the disease. The medications used to treat MS are divided into four categories: disease-modifying therapies, immunosuppressants, antispasmodics, and corticosteroids. Disease-modifying therapies can reduce irreversible damage to nerve cells, slow the development of new MS lesions, reduce relapses, and improve overall functioning. Immunosuppressants suppress the immune system’s attack on the nervous system, and can slow down or stop the progression of MS. Antispasmodics help reduce muscle spasms, while corticosteroids can reduce the length and severity of MS relapses. Taken together, the various types of MS medications can help people manage the symptoms of MS, improve their quality of life, and reduce the need for other treatments.

← International Journal of Multiple Sclerosis and Related Disorders

Related Articles

21 article(s) found
Apical Hypertrophic Cardiomyopathy and Multiple Coronary Artery-Left Ventricular Fistulas: A Case Report.
Full-text HTML Download PDF Download XML
Multiple Cerebral, Calcified and Infected Hydatid Cysts Case Report and Literature Review
Full-text HTML Download PDF Download XML
Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis
Full-text HTML Download PDF Download XML
Neurovascular Reactivity after Repeated Attacks in Patients with Multiple Sclerosis
Full-text HTML Download PDF Download XML
Non-Syndromic Multiple Keratocystic Odontogenic Tumor: A Case Report
Full-text HTML Download PDF Download XML
Overcoming Recruitment Challenges for Securing a Survey Sample of Caregivers of Community-Dwelling Older Adults with Multiple Chronic Conditions
Full-text HTML Download PDF Download XML
The Development and Evaluation of A Multiplex Real-Time PCR Assay for the Detection of ESBL Genes in Urinary Tract Infections
Full-text HTML Download PDF Download XML
Comparison of an HPLC-MS/MS Method with Multiple Commercial ELISA Kits on the Determination of Levels of 8-oxo-7,8-Dihydro-2'-Deoxyguanosine in Human Urine
Full-text HTML Download PDF Download XML
Prevalence and Determinants of Metabolic Syndrome in Schizophrenia Patients Treated with Antipsychotics Medications
Full-text HTML Download PDF Download XML
Lenalidomide-Induced High Grade Fever in a Patient with Multiple Myeloma: A Case Report
Full-text HTML Download PDF Download XML
Ultraviolet B Phototherapy Intervention in Patients with Multiple Sclerosis: A Prospective, Randomized Pilot Trial
Full-text HTML Download PDF Download XML
The Genetic Multiplicity- Multiple Endocrine Neoplasia type I
Full-text HTML Download PDF Download XML
RETRACTED: Amino Acid Imbalance in Atherosclerosis
Full-text HTML Download PDF Download XML
Comparative Analysis of Atherosclerosis Risk Factors in the Staff of the Tbilisi (Georgia) Cleaning Service
Full-text HTML Download PDF Download XML
A Case Report on Challenging Management of Multiple Neoplasms in Elderly
Full-text HTML Download PDF Download XML
An Uncommon Complication of Multiple Myeloma in a Post Bone Marrow Transplant patient–Plasma Cell Pleocytosis
Full-text HTML Download PDF Download XML
Fragiles but Resilient. The Key Strategies to Cope with Pandemic in Persons with Multiple Sclerosis. A Controlled Web Survey
Full-text HTML Download PDF Download XML
Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People With Multiple Sclerosis: A Report From Iran
Full-text HTML Download PDF Download XML
Peripheral Third Cranial Nerve Palsy in A Patient With Pediatric Form of Multiple Sclerosis
Full-text HTML Download PDF Download XML
An updated review: women's concerns following miscarriage on multiple social media platforms
Full-text HTML Download PDF Download XML
Retraction Note: Amino Acid Imbalance in Atherosclerosis
Full-text HTML Download PDF Download XML